Emicizumab-kxwh Subcutaneous and Eribulin Mesylate
Determining the interaction of Emicizumab-kxwh Subcutaneous and Eribulin Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: eribulin
Brand name: Halaven
Synonyms: Eribulin, EriBULin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Erivedge
- Emicizumab-kxwh Subcutaneous-Erleada
- Emicizumab-kxwh Subcutaneous-Erlotinib
- Emicizumab-kxwh Subcutaneous-Erlotinib Tablets
- Emicizumab-kxwh Subcutaneous-Errin
- Emicizumab-kxwh Subcutaneous-Ertapenem
- Eribulin Mesylate-Emla
- Eribulin Mesylate-Emla Topical
- Eribulin Mesylate-Emo-Cort Scalp Solution Topical application
- Eribulin Mesylate-Emo-Cort Topical application
- Eribulin Mesylate-Emoquette
- Eribulin Mesylate-Empagliflozin